Tomorrow, the Judicial Panel on Multidistrict Litigation (JPML) is scheduled to revisit whether to create a multidistrict litigation (MDL) docket for cases filed by individuals who have suffered kidney problems after taking proton pump inhibitors (PPIs), such as Nexium, Prilosec, Prevacid and others. A MDL is a type of legal proceeding that helps federal courts efficiently manage many...
Categories: Testosterone Heart Attack/Stroke Lawsuits
On July 24, 2017, a Chicago jury found in favor of claimant Jesse Mitchell in the second, much-anticipated AndroGel bellwether trial that started on July 5 in the testosterone replacement therapy (TRT) multidistrict litigation in the U.S. District Court for the Northern District of Illinois (Jesse Mitchell, et al. v. AbbVie, Inc., No. 14-9178, N.D....
Categories: Testosterone Heart Attack/Stroke Lawsuits
Recently, the second, much-anticipated AndroGel bellwether trial started on July 5 in the testosterone replacement therapy (TRT) multidistrict litigation in the U.S. District Court for the Northern District of Illinois (Jesse Mitchell, et al. v. AbbVie, Inc., No. 14-9178, N.D. Ill.). This claim is one of thousands filed by men who suffered serious side effects...
Categories: Consumer Recalls
On June 27, 2017 a recall was initiated by American Promotional Events for its TNT Red, White and Blue Smoke fireworks (manufactured in China) as these fireworks can explode unexpectedly after being lit, posing burn and injury hazards to consumers. Approximately 36,100 units have been recalled. Per the recall, “The recalled fireworks are pyrotechnic devices...
Categories: Medical Drug Safety
A cohort study of 140,352 diabetics showed that sodium-glucose cotransporter 2 (SGLT2 inhibitors) diabetes drugs were associated with approximately twice the risk of diabetic ketoacidosis as were dipeptidyl peptidase-4 (DPP4 inhibitors) diabetes drugs according to a recent letter to the New England Journal of Medicine. SGLT2 inhibitors are a class of prescription medicines that are...
Categories: Uncategorized
Recently, the American Association for Justice (AAJ) released a report, From Accutane to Zonite: A History of Dangerous Drugs & Devices Marketed to Women, discussing how women have been disproportionately exposed to dangerous drugs and devices. This compelling report profiles some of the most harmful medical products that have been marketed to women and highlights...
Categories: Uncategorized
Today, a federal jury in Kansas City, Kansas ordered Syngenta, an agribusiness giant, to pay nearly $218 million to more than 7,000 Kansas farmers over its decision to commercialize a genetically modified strain of corn before China approved it. When Chinese officials began refusing U.S. corn shipments in approximately 2013, corn prices plummeted causing catastrophic...
Individuals who have suffered kidney problems after taking proton pump inhibitors (PPIs), such as Nexium, Prilosec, Prevacid and others, have asked again to have their lawsuits centralized in federal court before a singe federal judge. Previously, they asked the Judicial Panel on Multidistrict Litigation (JPML) to create a multidistrict litigation (MDL) docket for the cases. A MDL is...
Categories: Dangerous and Defective Consumer Products
On Tuesday, the San Francisco Board of Supervisors unanimously approved a ban on the sale of flavored nicotine-laced liquid used in electronic cigarettes and flavored tobacco products, saying nicotine masked flavors like cotton candy, banana cream, watermelon, mint and other flavors entices kids into a lifetime of addiction and are disproportionately marketed to minority populations...
Categories: Birth Defect Lawsuits
Recently, on June 9th, a federal jury in Illinois awarded $15 million in compensation to a California child born with a split spine and spina bifida as a result of his mother’s use of Depakote during pregnancy. (E.G., et. al. v. Abbott Laboratories, 15-cv-00702, U.S. District Court, Southern District of Illinois) Specifically, the jury found...
Copyright ©2025 Borgess Law
Law Firm Web Design by Black Fin